VANOS Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Vanos, and what generic alternatives are available?

Vanos is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in VANOS is fluocinonide. There are nine drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Vanos

A generic version of VANOS was approved as fluocinonide by TARO on June 10^th, 1987.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for VANOS?
What are the global sales for VANOS?
What is Average Wholesale Price for VANOS?

Summary for VANOS

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	72
Patent Applications:	4,878
Drug Prices:	Drug price information for VANOS
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for VANOS
What excipients (inactive ingredients) are in VANOS?	VANOS excipients list
DailyMed Link:	VANOS at DailyMed

Drug patent expirations by year for VANOS

Pharmacology for VANOS

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Paragraph IV (Patent) Challenges for VANOS

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
VANOS	Cream	fluocinonide	0.1%	021758	1	2008-01-31

US Patents and Regulatory Information for VANOS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	VANOS	fluocinonide	CREAM;TOPICAL	021758-001	Feb 11, 2005	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for VANOS

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	VANOS	fluocinonide	CREAM;TOPICAL	021758-001	Feb 11, 2005	⤷ Sign Up	⤷ Sign Up
Bausch	VANOS	fluocinonide	CREAM;TOPICAL	021758-001	Feb 11, 2005	⤷ Sign Up	⤷ Sign Up
Bausch	VANOS	fluocinonide	CREAM;TOPICAL	021758-001	Feb 11, 2005	⤷ Sign Up	⤷ Sign Up
Bausch	VANOS	fluocinonide	CREAM;TOPICAL	021758-001	Feb 11, 2005	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for VANOS

See the table below for patents covering VANOS around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	2010280689	COMPOSITION AND METHOD FOR ENHANCING CORTICOSTEROID DELIVERY	⤷ Sign Up
Canada	2471041	COMPOSITIONS ET PROCEDES FAVORISANT L'ADMINISTRATION DE CORTICOSTEROIDES (COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTERIOD DELIVERY)	⤷ Sign Up
China	1617730		⤷ Sign Up
Israel	162581		⤷ Sign Up
European Patent Office	2363150		⤷ Sign Up
European Patent Office	1465636		⤷ Sign Up
Mexico	PA04006014	COMPOSICIONES Y METODOS PARA INCREMENTAR EL SUMINISTRO DE CORTICOSTEROIDE. (COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTERIOD DELIVERY.)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for VANOS

Pharmacology for VANOS

Paragraph IV (Patent) Challenges for VANOS

Make Better Decisions: Try a trial or see plans & pricing